Ferreira-Hermosillo, Aldo
Molina-Ayala, Mario Antonio
Molina-Guerrero, Diana
Garrido-Mendoza, Ana Pamela
Ramírez-Rentería, Claudia
Mendoza-Zubieta, Victoria
Espinosa, Etual
Mercado, Moisés
Funding for this research was provided by:
Instituto Mexicano del Seguro Social (FIS/IMSS/PROT/G17-2/1752)
Article History
Received: 5 August 2019
Accepted: 30 January 2020
First Online: 14 February 2020
Ethics approval and consent to participate
: The protocol has been approved by the Research and Ethics Committee of the IMSS (CNIC registry number: R-2016-785-094). The procedures are in compliance with local ethical regulations, the Mexican Law of General Health regarding Health Research, the institutional regulations, and the Declaration of Helsinki of 1975 and its amendments. It is also in compliance with the currently approved international codes and norms regarding Good Clinical Practice in Clinical Investigation.Each patient will sign an informed consent prior to enrollment<b>.</b> The patients will be invited personally when they attend their regular visits to the outpatient clinic. The principal investigator or one of the co-investigators will also sign the consent. The patient will be informed about the freedom to withdraw consent at any time during the investigation.The study is sponsored by the IMSS.
: AFH is the Associate Editor of the BMC Endocrine Disorders Journal. The remaining authors declare that they have no competing interests.